Measurement of Noradrenaline Concentrations Using Different Dilution Methods

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT04772599
Collaborator
(none)
50
1
4.3
11.7

Study Details

Study Description

Brief Summary

Norepinephrine is the vasopressor of choice for the treatment of peri-anesthetic arterial hypotension. The use of this drug at significantly lower concentrations (dilution factor between 40 and 200) than the commercial preparation is increasingly common in the operating room ("baby-noradrenaline").

In addition, dilution errors are potentially serious for the patient (hypertensive peak) The preparation of precise dilutions is an important factor for the safe use of this medically In this study, the investigators wish to compare the dilution method of the protocol with another method of preparation (left to the free choice of the participant).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    50 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Measurement of Noradrenaline Concentrations Using Different Dilution Methods
    Actual Study Start Date :
    Feb 21, 2021
    Anticipated Primary Completion Date :
    Jul 1, 2021
    Anticipated Study Completion Date :
    Jul 1, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Measurement of noradrenaline concentrations using different dilution methods [1 hour after the preparation of the noradrenaline solutions]

      Measurement methods: High performance liquid chromatography Measurement of the concentration of noradrenaline in the biochemical laboratory of the University Hospitals of Strasbourg

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion criteria:
    • Adult person,

    • Employee of Strasbourg University Hospitals,

    • Likely to have to prepare anesthesia drugs in the operating room (intern, hospital student, IADE, IADE student)

    Exclusion criteria:
    • Subject's refusal to participate in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Strasbourg University Hospitals - Anesthesia-intensive care unit Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT04772599
    Other Study ID Numbers:
    • 7632
    First Posted:
    Feb 26, 2021
    Last Update Posted:
    Feb 26, 2021
    Last Verified:
    Feb 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 26, 2021